Nagata is to Phosphatidylserine as Dmitry Gabrilovich is to MDSC's...and WHO knows, maybe many feared that Peregrine interfearedon many other Big Pharmas legacy.
Nagata is still at it and all the talk about PS exposure will all lead to PS Targeting
Cell Death Gordon Research Conference
New Concepts in Cell Death Research: From Basic Mechanisms to Clinical Opportunities
Dates July 3-8, 2016 Location PGA Catalunya Business and Convention Centre Girona, Spain
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!